Century Therapeutics (IPSC) Tax Provisions (2022 - 2024)
Century Therapeutics (IPSC) posted quarterly Tax Provisions of $1.4 million for Q4 2024, up 258.34% year-over-year from $383989.7 in Q1 2024, and up 17300.0% quarter-over-quarter from -$8000.0 in Q3 2024.
Powered by 
Analysis
Century Therapeutics (IPSC) Tax Provisions (2022 - 2024) Analysis & Trends
Century Therapeutics (IPSC) has reported Tax Provisions for 3 consecutive years, with $1.4 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Tax Provisions rose 258.34% year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $1.4 million (down 26.05% YoY), while the FY2025 annual figure was -$2.0 million, down 245.76% from the prior year.
- Tax Provisions climbed to $1.4 million in Q4 2024 per IPSC's latest filing, from -$8000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.4 million in Q4 2024 and bottomed at -$869000.0 in Q4 2023.
- Historically, Tax Provisions has averaged $280250.0 across 3 years, with a median of $23500.0 in 2022.
- On a YoY basis, Tax Provisions climbed as much as 7450.0% in 2023 and fell as far as 2815.62% in 2023.
- Century Therapeutics' Tax Provisions stood at $32000.0 in 2022, then sank by 2815.62% to -$869000.0 in 2023, then surged by 258.34% to $1.4 million in 2024.
- Business Quant data shows IPSC's Tax Provisions at $1.4 million in Q4 2024, -$8000.0 in Q3 2024, and $22000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Century Therapeutics | 439.34 Mn | 179.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -26.17 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -866,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 950,000.00 |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 16,000.00 |